Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cellsSemih U. Tareen, Peter Berglund, Christopher J. Nicolai et al.|Cancer Research|2014Cited by 0